566 related articles for article (PubMed ID: 26073311)
1. Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.
Schulz R; Görge PM; Görbe A; Ferdinandy P; Lampe PD; Leybaert L
Pharmacol Ther; 2015 Sep; 153():90-106. PubMed ID: 26073311
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 and Mitochondria in Cardiovascular Health and Disease.
Boengler K; Schulz R
Adv Exp Med Biol; 2017; 982():227-246. PubMed ID: 28551790
[TBL] [Abstract][Full Text] [Related]
3. [Remodeling of cardiac gap junctions and arrhythmias].
Yu ZB; Sheng JJ
Sheng Li Xue Bao; 2011 Dec; 63(6):586-92. PubMed ID: 22193455
[TBL] [Abstract][Full Text] [Related]
4. Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.
Rodríguez-Sinovas A; Sánchez JA; Valls-Lacalle L; Consegal M; Ferreira-González I
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922534
[TBL] [Abstract][Full Text] [Related]
5. Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction.
Hawat G; Hélie P; Baroudi G
J Mol Cell Cardiol; 2012 Oct; 53(4):559-66. PubMed ID: 22841862
[TBL] [Abstract][Full Text] [Related]
6. Connexin 43 and ischemic preconditioning.
Schulz R; Heusch G
Cardiovasc Res; 2004 May; 62(2):335-44. PubMed ID: 15094353
[TBL] [Abstract][Full Text] [Related]
7. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue.
Contreras JE; Sánchez HA; Véliz LP; Bukauskas FF; Bennett MV; Sáez JC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):290-303. PubMed ID: 15572178
[TBL] [Abstract][Full Text] [Related]
8. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43.
Wu Y; Gu EW; Zhu Y; Zhang L; Liu XQ; Fang WP
Int Immunopharmacol; 2012 Jul; 13(3):341-6. PubMed ID: 22561119
[TBL] [Abstract][Full Text] [Related]
9. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury.
Hawat G; Benderdour M; Rousseau G; Baroudi G
Pflugers Arch; 2010 Aug; 460(3):583-92. PubMed ID: 20514543
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 and myocardial ischemia: potential pharmacological implication for cardioprotection.
Barau C; Ghaleh B; Berdeaux A; Morin D
Fundam Clin Pharmacol; 2015 Feb; 29(1):1-9. PubMed ID: 24990103
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice.
Morel S; Braunersreuther V; Chanson M; Bouis D; Rochemont V; Foglia B; Pelli G; Sutter E; Pinsky DJ; Mach F; Kwak BR
Cardiovasc Res; 2014 May; 102(2):329-37. PubMed ID: 24639196
[TBL] [Abstract][Full Text] [Related]
12. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
14. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
Bencsik P; Pálóczi J; Kocsis GF; Pipis J; Belecz I; Varga ZV; Csonka C; Görbe A; Csont T; Ferdinandy P
Pharmacol Res; 2014 Feb; 80():36-42. PubMed ID: 24380772
[TBL] [Abstract][Full Text] [Related]
15. Structure of cardiac gap junction intercellular channels.
Yeager M
J Struct Biol; 1998; 121(2):231-45. PubMed ID: 9615440
[TBL] [Abstract][Full Text] [Related]
16. Perturbing plasma membrane hemichannels attenuates calcium signalling in cardiac cells and HeLa cells expressing connexins.
Verma V; Hallett MB; Leybaert L; Martin PE; Evans WH
Eur J Cell Biol; 2009 Feb; 88(2):79-90. PubMed ID: 18951659
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion.
Retamal MA; Schalper KA; Shoji KF; Orellana JA; Bennett MV; Sáez JC
J Membr Biol; 2007 Aug; 218(1-3):49-63. PubMed ID: 17705051
[TBL] [Abstract][Full Text] [Related]
18. Role of connexin 43 in cardiovascular diseases.
Michela P; Velia V; Aldo P; Ada P
Eur J Pharmacol; 2015 Dec; 768():71-6. PubMed ID: 26499977
[TBL] [Abstract][Full Text] [Related]
19. Regulation of connexin hemichannel activity by membrane potential and the extracellular calcium in health and disease.
Fasciani I; Temperán A; Pérez-Atencio LF; Escudero A; Martínez-Montero P; Molano J; Gómez-Hernández JM; Paino CL; González-Nieto D; Barrio LC
Neuropharmacology; 2013 Dec; 75():479-90. PubMed ID: 23587648
[TBL] [Abstract][Full Text] [Related]
20. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening.
Wang N; De Bock M; Decrock E; Bol M; Gadicherla A; Bultynck G; Leybaert L
Neuropharmacology; 2013 Dec; 75():506-16. PubMed ID: 24007825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
